|
AutoLumo S900 – Fully Automated Chemiluminescent Immunoassay Analyzer for Clinical Laboratories
Chinese diagnostics giant Autobio targets the middle of the market with a machine that delivers central-lab throughput in a footprint suited to satellite labs and smaller hospitals.
Clinical labs face a persistent tension: rising test volumes versus fixed floor space. The AutoLumo S900, from Autobio Diagnostics, resolves this by packing high-throughput chemiluminescent immunoassay (CLIA) capability into a compact analyzer designed for small- and medium-sized laboratories.
The system supports random-access testing across more than 150 assays—covering tumor markers, hormones, infectious diseases, cardiac markers, and autoimmune panels. Random access means no batching delays: samples enter the workflow individually, allowing STAT results to interrupt routine runs without manual reconfiguration.
Key engineering choices include five-stage magnetic separation cleaning and non-contact vortex mixing, both aimed at reducing carryover and improving precision without increasing reagent consumption. Real-time system monitoring and automated reagent handling further reduce hands-on labor, a tangible benefit for labs with limited technical staff.
Autobio’s positioning here is deliberate. The S900 fills the gap between fully manual benches and sprawling high-volume platforms—a segment that includes hospital satellite labs, blood banks, and public health facilities. For these operators, throughput per square meter matters as much as raw test count.
The device also reflects broader trends in China’s in vitro diagnostics (IVD) supply chain: domestic manufacturers now offer menu breadth and automation features that compete directly with established multinationals, often at lower total cost of ownership.
For lab operators balancing budget constraints with expanding test menus, the AutoLumo S900 represents a pragmatic upgrade path—one that compresses central-lab workflow into a benchtop footprint without compromising assay coverage.
Why it matters:
The S900 signals that Chinese IVD manufacturers are moving beyond low-cost replication into targeted product-market fit. For procurement teams, it offers a viable alternative to legacy platforms, particularly in space-constrained settings where throughput cannot be sacrificed.
View Product →
|
ScientificChina — tracking China’s science, technology, and industrial systems through the lens of real-world products.
Follow ScientificChina for deeper insight into the infrastructure behind global innovation.
Visit ScientificChina.
|
|
No products in the cart.